| | | | | European medical cannabis company EMMAC announced on Monday a research partnership with UK biotechnology company Hyris Limited to develop a library of genetic profiles of existing cannabis varieties. | | |
| | | The Syrian war has inflicted all kinds of hardships on Najwa Abdelaziz but she still manages to make light of one of them. "The uprising ruined my teeth," she jokes while getting dental care for the first time in years in the back of a truck. | | |
| | | At least 129 children have now died of Acute Encephalitis Syndrome (AES) in the town of Muzaffarpur in the eastern Indian state of Bihar since an outbreak earlier this month, a medical official said on Sunday. | | |
| | | Thailand will ban pig imports from Laos for 90 days after its neighbor confirmed the first outbreak of deadly African swine fever, an official notice said. | | |
| | | The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals' drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as "female Viagra". | | |
| | | (Reuters Health) - Adults with clogged arteries carrying blood to the heart may be more prone to cognitive decline than their counterparts without such cardiac problems, a study suggests. | | |
| | | (Reuters Health) - Children and young adults with chronic conditions like asthma, diabetes, and ADHD may be more likely to develop mental illness than youth who don't have physical health problems, a U.S. study suggests. | | |
| | | (Reuters Health) - Many pregnant women in the U.S. may not be getting enough of certain crucial nutrients, while others may be getting too much, a new study suggests. | | |
| | | (Reuters Health) - Kids may have a much better - and safer - time at summer camp when parents plan ahead to make sure programs are a good fit for their child and capable of handling any health issues that may arise, U.S. pediatricians say. | | |
| | | Missouri health officials on Friday refused to renew the license of the state's only abortion clinic, but the facility will remain open for now as a judge left in place an injunction blocking its closure. | | |
| | | A U.S. group that reviews the value of medicines issued a critical report on Novartis's new multiple sclerosis drug Mayzent, calling its $88,561 list price "far out of line" compared with its benefits for patients. | | |
|
| |
